Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Generalized cost-effectiveness analysis for national-level priority-setting in the health sector.

Hutubessy R, Chisholm D, Edejer TT.

Cost Eff Resour Alloc. 2003 Dec 19;1(1):8.

2.

Cost-Effectiveness and Affordability of Interventions, Policies, and Platforms for the Prevention and Treatment of Mental, Neurological, and Substance Use Disorders.

Levin C, Chisholm D.

In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14. Chapter 12.

3.

Critical issues in the economic evaluation of interventions against communicable diseases.

Hutubessy RC, Bendib LM, Evans DB.

Acta Trop. 2001 Mar 30;78(3):191-206. Review.

PMID:
11311183
4.

Generalised cost-effectiveness analysis: an aid to decision making in health.

Hutubessy RC, Baltussen RM, Torres-Edejer TT, Evans DB.

Appl Health Econ Health Policy. 2002;1(2):89-95. Review.

PMID:
14619255
5.

Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Tantivess S, Teerawattananon Y, Mills A.

Pharmacoeconomics. 2009;27(11):931-45. doi: 10.2165/11314710-000000000-00000. Review.

PMID:
19888793
6.

Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.

Chen YF, Madan J, Welton N, Yahaya I, Aveyard P, Bauld L, Wang D, Fry-Smith A, Munafò MR.

Health Technol Assess. 2012;16(38):1-205, iii-v. doi: 10.3310/hta16380. Review.

7.

Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement.

Whitaker R, Hendry M, Aslam R, Booth A, Carter B, Charles JM, Craine N, Tudor Edwards R, Noyes J, Ives Ntambwe L, Pasterfield D, Rycroft-Malone J, Williams N.

Health Technol Assess. 2016 Feb;20(16):1-214. doi: 10.3310/hta20160. Review.

8.

The clinical effectiveness, cost-effectiveness and acceptability of community-based interventions aimed at improving or maintaining quality of life in children of parents with serious mental illness: a systematic review.

Bee P, Bower P, Byford S, Churchill R, Calam R, Stallard P, Pryjmachuk S, Berzins K, Cary M, Wan M, Abel K.

Health Technol Assess. 2014 Feb;18(8):1-250. doi: 10.3310/hta18080. Review.

9.

Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P.

Value Health. 2007 Sep-Oct;10(5):336-47.

10.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

11.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

12.

Generalisability in economic evaluation studies in healthcare: a review and case studies.

Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.

Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.

13.

The role of patient preferences in cost-effectiveness analysis: a conflict of values?

Brazier JE, Dixon S, Ratcliffe J.

Pharmacoeconomics. 2009;27(9):705-12. doi: 10.2165/11314840-000000000-00000. Review.

PMID:
19757864
14.

The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.

Pavey TG, Anokye N, Taylor AH, Trueman P, Moxham T, Fox KR, Hillsdon M, Green C, Campbell JL, Foster C, Mutrie N, Searle J, Taylor RS.

Health Technol Assess. 2011 Dec;15(44):i-xii, 1-254. doi: 10.3310/hta15440. Review.

15.

Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD007768. doi: 10.1002/14651858.CD007768.pub3. Review.

PMID:
24777444
16.

Summary.

Gelband H, Jha P, Sankaranarayanan R, Gauvreau CL, Horton S.

In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 1.

17.

Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, Price MJ, Bates EJ, Turner AM, Bayliss S, Moore D, Singh S, Adab P, Fitzmaurice DA, Jowett S, Jolly K.

Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360. Review.

18.

Adaptive e-learning to improve dietary behaviour: a systematic review and cost-effectiveness analysis.

Harris J, Felix L, Miners A, Murray E, Michie S, Ferguson E, Free C, Lock K, Landon J, Edwards P.

Health Technol Assess. 2011 Oct;15(37):1-160. doi: 10.3310/hta15370. Review.

20.

Health economics in developing countries.

Abel-Smith B.

J Trop Med Hyg. 1989 Aug;92(4):229-41. Review.

PMID:
2503621

Supplemental Content

Support Center